MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 27.02.2026
Establishment Labs Holdings Langfristige Verbindlichkeiten 2011-2026 | ESTA
Langfristige Verbindlichkeiten Jährlich Establishment Labs Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 53.7 M | 30.6 M | 4.67 M | 1.42 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 53.7 M | 1.42 M | 22.6 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 188.31 | -0.66 % | $ 13.2 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 93.7 | -1.23 % | $ 12.7 B | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.35 | -4.86 % | $ 6.52 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | - | - | $ 1.28 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
13 B | $ 329.01 | 0.46 % | $ 126 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.84 | - | $ 388 M | USA |
 |
Varex Imaging Corporation
VREX
|
419 M | $ 12.71 | 1.44 % | $ 526 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
Vivos Therapeutics
VVOS
|
587 K | $ 0.86 | 2.46 % | $ 8.84 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | - | - | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
PAVmed
PAVM
|
300 K | $ 8.4 | -6.67 % | $ 5.63 M | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 83.46 | -0.82 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.34 | -2.62 % | $ 494 M | USA |